Abstract
Despite the adoption of antifungal prophylaxis, fungal infections remain a significant concern in lung transplant recipients. Indeed, some concern exists that such prophylaxis may increase the risk of infection with drug-resistant fungal organisms. Here, we describe a case of disseminated Scedosporium prolificans infection, presenting as pericarditis, which developed in a lung transplant patient receiving prophylactic voriconazole for 8 months. The epidemiology and clinical presentation of S. prolificans infections are reviewed, and controversies surrounding antifungal prophylaxis and the development of resistant infections are discussed.
© 2013 John Wiley & Sons A/S.
MeSH terms
-
Aged
-
Aneurysm, Infected / diagnosis
-
Aneurysm, Infected / microbiology*
-
Aneurysm, Infected / prevention & control
-
Antifungal Agents / therapeutic use
-
Aortic Aneurysm / diagnosis
-
Aortic Aneurysm / microbiology*
-
Aortic Aneurysm / prevention & control
-
Drug Resistance, Fungal / drug effects
-
Female
-
Humans
-
Lung Transplantation*
-
Mycoses / diagnosis
-
Mycoses / microbiology*
-
Mycoses / prevention & control
-
Pericarditis / diagnosis
-
Pericarditis / microbiology*
-
Pericarditis / prevention & control
-
Pyrimidines / therapeutic use*
-
Scedosporium / isolation & purification*
-
Triazoles / therapeutic use*
-
Voriconazole
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Voriconazole